LBLaura Beatriz Gomes Brandão

Laura Beatriz Gomes Brandão

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Beatriz Gomes Brandão has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Interventions and the Impact of Pharmacist Consultations on the Management of Minor Ailments in Brazil

    by Letícia Isabella Ferreira Brandão, Gustavo Pereira Calado, Laura Beatriz Gomes Brandão, Maria Christina dos Santos Verdam, Débora Santos Lula Barros, Rodrigo Fonseca Lima, Rafael Santos Santana

    Background: Minor ailments account for a substantial proportion of demands in community pharmacies, particularly in contexts marked by high self‐medication and risk of inappropriate medication use. Objective: To evaluate the adherence of pharmacological and non‐pharmacological interventions to clinical guidelines for minor ailment management and to analyze patient‐reported clinical outcomes. Methods: This observational, quantitative, descriptive study analyzed 227 pharmacist consultations. Interventions were individually reviewed, classified according to the GRADE system, and categorized according to adherence to pharmaceutical care guidelines. One week after the consultation, patients completed a questionnaire on clinical evolution. Results: A total of 332 pharmacological and 549 non‐pharmacological interventions were identified, with guideline adherence rates of 74.4% and 73.4%, respectively. The best performance was observed for Women's Health conditions, whereas gastrointestinal conditions showed the lowest adherence rates and the highest proportion of low‐quality evidence. Among 148 patients followed up, 75.7% reported complete symptom resolution and 24.3% partial improvement. Conclusions: The use of clinical guidelines contributed to more consistent interventions and favorable clinical outcomes, although challenges remain regarding gastrointestinal conditions and the standardization of pharmaceutical practice.